Evaluation of Kidney Function – Part 1: Use of “Race-Less” eGFR
Estimated glomerular filtration rate (eGFR) equations are used for kidney disease staging, to assess kidney disease progression, and drug dosing. Which equation to use is a controversial area. This module will discuss the newest equations that removed race as a variable.. This module focuses on the basis for these changes, compares accuracy of these new equations to the older equations and demonstrates the rationale for using non-indexed results from this new equation for drug-related decision making.
By the end of this module, learners will be able to:
- Articulate rationale for replacing older raced based equations with non-race-based ‘race-less’ estimated glomerular filtration rate (eGFR) equations
- Explain limitations of older raced based methods to estimate kidney function for the purpose of drug-related decision-making
- Identify benefits and limitations for using serum creatinine and cystatin-C based methods to estimate kidney function
- Justify use of non-indexed vs indexed results in underweight and overweight individuals for drug-related decision-making
Time: 30 minutes
The following planners and presenters have disclosed a financial relationship with an ineligible company:
- Katie Cardone, PharmD, BCACP, FNKF, FASN, FCCP - Grants/Research Support [Merck & Co], Consultant [Vifor, Otsuka], Honorarium [Pharmacy Times]
- Calvin Meaney, PharmD, BCPS - Speaker's Bureau [GSK], Consultant [GSK, Wolters-Kluwer (Lexicorp)]
- Wendy St. Peter, FCCP, FASN, FNKF - Consultant [GSK]
There are no conflicts of interest or financial relationships with an ineligible company that have been disclosed by the rest of the planners and presenters of this learning activity.
All relevant financial relationships have been mitigated.
In support of improving patient care, this activity is planned and implemented by The National Center for Interprofessional Practice and Education Office of Interprofessional Continuing Professional Development (OICPD). The OICPD is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians: The National Center for Interprofessional Practice and Education designates this live activity for . 5 hours AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with their participation.
Physician Assistants: The American Academy of Physician Assistants (AAPA) accepts credit from organizations accredited by the ACCME.
Nurses: Participants will be awarded .5 contact hours of credit for attendance in this module.
Nurse Practitioners: The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.
Pharmacists: This activity is approved for .5 contact hours. UAN: JA4008105-9999-23-013-H01-P.
IPCE: This activity was planned by and for the healthcare team, and learners will receive Interprofessional Continuing Education (IPCE) credits for learning and change.
